Optimizing Cardiac Rehabilitation in Heart Failure: Comprehensive Insights, Barriers, and Future Strategies

Francisco Epelde1,2

  • 1Internal Medicine Consultant, Hospital Universitari Parc Taulí, Sabadell, 08208 Sabadell, Spain.

PubMed

Insights

Cardiac rehabilitation (CR) improves outcomes for heart failure (HF) patients but is underused. This review highlights barriers and proposes strategies like personalized programs and telehealth to increase CR uptake and enhance patient quality of life.

Area of Science:

  • Cardiology
  • Rehabilitation Medicine

Background:

  • Heart failure (HF) is a widespread cardiovascular condition with substantial morbidity, mortality, and economic burden.
  • Cardiac rehabilitation (CR) is a proven intervention for improving HF patient outcomes, including functional capacity and quality of life.
  • Despite evidence, CR utilization in HF patients remains suboptimal.

Purpose of the Study:

  • To comprehensively review the role of CR in managing heart failure.
  • To identify barriers hindering CR implementation in HF patients.
  • To propose strategies for enhancing CR accessibility and effectiveness.

Main Methods:

  • Literature review focusing on exercise-based rehabilitation, psychosocial support, and education in HF.
  • Analysis of patient-related, provider-related, and systemic barriers to CR.
  • Exploration of innovative approaches for CR delivery.

Main Results:

  • CR effectively enhances functional capacity, reduces hospital readmissions, and improves quality of life in HF patients.
  • Significant barriers to CR include patient adherence issues, provider awareness gaps, and systemic healthcare challenges.
  • Personalized CR programs, telehealth, and integration into standard care show promise for increasing uptake.

Conclusions:

  • Optimizing CR delivery is crucial for improving outcomes in heart failure patients.
  • Addressing identified barriers through targeted strategies is essential for increasing CR utilization.
  • Future efforts should focus on innovative and integrated approaches to maximize CR benefits for HF survivors.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
1
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1
Heart Failure V: Nursing Interventions01:30

Heart Failure V: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
1
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1